JEL Stock Overview
JEOL Ltd. engages in the research, development, manufacture, and marketing of scientific and metrology instruments, semiconductor and industrial equipment, and medical equipment worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for JEL from our risk checks.
JEOL Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥42.20 |
| 52 Week High | JP¥45.60 |
| 52 Week Low | JP¥26.00 |
| Beta | 1.16 |
| 1 Month Change | 11.64% |
| 3 Month Change | 12.83% |
| 1 Year Change | 57.46% |
| 3 Year Change | -5.38% |
| 5 Year Change | 143.03% |
| Change since IPO | 327.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| JEL | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -4.1% | -2.1% | -0.8% |
| 1Y | 57.5% | -3.3% | 1.0% |
Return vs Industry: JEL exceeded the German Medical Equipment industry which returned -3.3% over the past year.
Return vs Market: JEL exceeded the German Market which returned 1% over the past year.
Price Volatility
| JEL volatility | |
|---|---|
| JEL Average Weekly Movement | 6.6% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: JEL has not had significant price volatility in the past 3 months.
Volatility Over Time: JEL's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1949 | 3,351 | Izumi Oi | www.jeol.co.jp |
JEOL Ltd. engages in the research, development, manufacture, and marketing of scientific and metrology instruments, semiconductor and industrial equipment, and medical equipment worldwide. The company operates through three segments: Scientific and Measuring Instruments Business, Industrial Equipment Business, and the Medical Equipment Business. It provides transmission electron microscopes; scanning electron microscopes; nuclear resonance and mass spectrometer; x-ray fluorescence spectrometer; electron diffractometer; ion beam application equipment, including specimen preparation equipment and multibeam systems; instruments for microarea and surface analysis, such as electron probe micro analyzers, auger microprobes, and photoelectron spectrometers; magnetic resonance equipment, such as nuclear magnetic resonance and electron spin resonance spectrometers; electron beam lithography systems; electron microscope for semiconductors; and clinical chemistry analyzers.
JEOL Ltd. Fundamentals Summary
| JEL fundamental statistics | |
|---|---|
| Market cap | €2.14b |
| Earnings (TTM) | €89.33m |
| Revenue (TTM) | €982.96m |
23.9x
P/E Ratio2.2x
P/S RatioIs JEL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JEL income statement (TTM) | |
|---|---|
| Revenue | JP¥161.87b |
| Cost of Revenue | JP¥90.17b |
| Gross Profit | JP¥71.70b |
| Other Expenses | JP¥56.99b |
| Earnings | JP¥14.71b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | 287.96 |
| Gross Margin | 44.30% |
| Net Profit Margin | 9.09% |
| Debt/Equity Ratio | 14.1% |
How did JEL perform over the long term?
See historical performance and comparison